Cadila Pharmaceuticals launches Vasograin Plus for treatment of migraines
Vasograin Plus represents a major advancement in the treatment of migraine
Vasograin Plus represents a major advancement in the treatment of migraine
EBITDA rose to Rs. 218.1 crore, a 14.8% year-on-year increase
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
Subscribe To Our Newsletter & Stay Updated